[1] |
Landy SJ, Donnai D. Incontinentia pigmenti (Bloch⁃Sulzberger syndrome)[J]. J Med Genet, 1993,30(1):53⁃59.
|
[2] |
Kenwrick S, Woffendin H, Jakins T, et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome[J]. Am J Hum Genet, 2001,69(6):1210⁃1217.
|
[3] |
Alabdullatif Z, Coulombe J, Steffann J, et al. Postzygotic mosaicism and incontinentia pigmenti in male patients: molecular diagnosis yield[J]. Br J Dermatol, 2018,178(4):e261⁃e262. doi: 10.1111/bjd.16092.
|
[4] |
Rashidghamat E, Hsu CK, Nanda A, et al. Incontinentia pigmenti in a father and daughter[J]. Br J Dermatol, 2016,175(5):1059⁃1060. doi: 10.1111/bjd.14615.
|
[5] |
林琳, 熊永强, 吕月娥, 等. 皮肤色素失禁症合并双眼视网膜病变一例[J]. 中华眼底病杂志, 2015,31(5):493⁃494. doi: 10.3760/cma.j.issn.1005⁃1015.2015.05.024.
|
[6] |
郑玉洁, 刘士瑞, 朱磊, 等. 46⁃XY型色素失禁症伴中枢神经系统受累一例[J]. 中华皮肤科杂志, 2013,46(6):446. doi: 10.3760/cma.j.issn.0412⁃4030.2013.06.028.
|
[7] |
Mariath LM, Santa MFD, Poziomczyk CS, et al. Intrafamilial clinical variability in four families with incontinentia pigmenti[J]. Am J Med Genet A, 2018,176(11):2318⁃2324. doi: 10. 1002/ajmg.a.40497.
|
[8] |
Minić S, Trpinac D, Obradović M. Incontinentia pigmenti diagnostic criteria update[J]. Clin Genet, 2014,85(6):536⁃542. doi: 10.1111/cge.12223.
|
[9] |
Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF⁃kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium[J]. Nature, 2000,405(6785):466⁃472. doi: 10.1038/35013114.
|
[10] |
Van Antwerp DJ, Martin SJ, Kafri T, et al. Suppression of TNF⁃alpha⁃induced apoptosis by NF⁃kappaB[J]. Science, 1996,274(5288):787⁃789.
|
[11] |
Steffann J, Raclin V, Smahi A, et al. A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti[J]. Prenat Diagn, 2004,24(5):384⁃388. doi: 10.1002/pd.889.
|
[12] |
Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF⁃kappaB activation[J]. Cell, 1998,93(7):1231⁃1240.
|
[13] |
Israël A. The IKK complex: an integrator of all signals that activate NF⁃kappaB?[J]. Trends Cell Biol, 2000,10(4):129⁃133.
|
[14] |
Fusco F, Bardaro T, Fimiani G, et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF⁃kappaB activation[J]. Hum Mol Genet, 2004,13(16):1763⁃1773. doi: 10.1093/hmg/ddh192.
|
[15] |
Conte MI, Pescatore A, Paciolla M, et al. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease[J]. Hum Mutat, 2014,35(2):165⁃177. doi: 10.1002/humu.22483.
|
[16] |
Okita M, Nakanishi G, Fujimoto N, et al. NEMO gene rearrangement (exon 4⁃10 deletion) and genotype⁃phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients[J]. J Dermatol, 2013, 40(4): 272⁃276. doi: 10.1111/1346⁃8138.12091.
|